Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C3H6O3 |
| Molecular Weight | 90.0779 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1OCOCO1
InChI
InChIKey=BGJSXRVXTHVRSN-UHFFFAOYSA-N
InChI=1S/C3H6O3/c1-4-2-6-3-5-1/h1-3H2
| Molecular Formula | C3H6O3 |
| Molecular Weight | 90.0779 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Trioxaquines: hybrid molecules for the treatment of malaria. | 2010-12 |
|
| Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes. | 2010-11-11 |
|
| A suitable preparation of N-sulfonyl-1,2,3,4-tetrahydroisoquinolines and their ring homologs with a reusable Preyssler heteropolyacid as catalyst. | 2010-11 |
|
| Interspecies comparison of the pharmacokinetics and oral bioavailability of 99-357, a potent synthetic trioxane antimalarial compound. | 2010-10-09 |
|
| Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins. | 2010-08-20 |
|
| Chain branching and termination in the low-temperature combustion of n-alkanes: 2-pentyl radical + O2, isomerization and association of the second O2. | 2010-07-29 |
|
| The pharmaceutical death-ride of dihydroartemisinin. | 2010-07-22 |
|
| (1R,3S,4R,4aS,7R,7aS,10R,12aR)-3-Azido-4,7,10-trimethyl-1,10-epidioxy-per-hydropyrano[4,3-j][1,2]benzodiox-epine. | 2010-06-26 |
|
| Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii. | 2010-05-13 |
|
| Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers. | 2010-04-28 |
|
| Formaldehyde in the indoor environment. | 2010-04-14 |
|
| Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose. | 2009-12-10 |
|
| Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid. | 2009-08 |
|
| Liquid chromatographic tandem mass spectrometric assay for quantification of 97/78 and its metabolite 97/63: a promising trioxane antimalarial in monkey plasma. | 2009-07-15 |
|
| Antimalarial peroxide dyads from natural artemisinin and hydroxyalkylated 1,2,4-trioxanes. | 2009-05-28 |
|
| Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells. | 2009-02-26 |
|
| Diastereoselective preparation of substituted delta-valerolactones. synthesis of (3R,4S)- and (3R,4R)-simplactones. | 2009-02-06 |
|
| Ferrocenium salts mediate para-tert-butylcalixarene synthesis. | 2008-11-30 |
|
| New strategy for the construction of epoxy-bridged tetrahydropyran frameworks from trioxane precursors: application to a concise synthesis of a Riesling acetal. | 2008-11-07 |
|
| Piperidine dispiro-1,2,4-trioxane analogues. | 2008-11-01 |
|
| Accretion reactions of octanal catalyzed by sulfuric acid: product identification, reaction pathways, and atmospheric implications. | 2008-10-01 |
|
| Elucidation of the natural artemisinin decomposition route upon iron interaction: a fine electronic redistribution promotes reactivity. | 2008-09-01 |
|
| 1,2,5,10,11,14-hexaoxadispiro[5.2.5.2]hexadecanes: novel spirofused bis-trioxane peroxides. | 2008-08-19 |
|
| Redetermination of 2,4,6-tricyclo-hexyl-1,3,5-trioxane. | 2008-06-19 |
|
| Photoinduced oxygen capture on immobilized dienone systems. First solid-phase synthesis of trioxane scaffolds. | 2008-04-26 |
|
| Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles. | 2008-04-10 |
|
| A sensitive and selective liquid chromatographic tandem mass spectrometric assay for simultaneous quantification of novel trioxane antimalarials in different biomatrices using sample-pooling approach for high throughput pharmacokinetic studies. | 2008-03-15 |
|
| Malaria-infected mice are cured by oral administration of new artemisinin derivatives. | 2008-02-28 |
|
| [Synthesis and antiviral activity of lupane triterpenoids with modified cycle E]. | 2008-01-05 |
|
| Hybrid molecules with a dual mode of action: dream or reality? | 2008-01 |
|
| Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys. | 2007-11-10 |
|
| Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1. | 2007-10-11 |
|
| Ensuring sustained ACT production and reliable artemisinin supply. | 2007-09-15 |
|
| Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. | 2007-08-29 |
|
| Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. | 2007-05-17 |
|
| New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria. | 2007-02-08 |
|
| Reactions of artemisinin and arteether with acid: implications for stability and mode of antimalarial action. | 2006-10-05 |
|
| Quantitative NMR spectroscopy of complex technical mixtures using a virtual reference: chemical equilibria and reaction kinetics of formaldehyde-water-1,3,5-trioxane. | 2006-07 |
|
| 8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria. | 2006-02 |
|
| Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins. | 2005-11 |
|
| New orally active spiro 1,2,4-trioxanes with high antimalarial potency. | 2005-10-15 |
|
| Conformational pathways of saturated six-membered rings. A static and dynamical density functional study. | 2005-09-15 |
|
| A high throughput approach for simultaneous estimation of multiple synthetic trioxane derivatives using sample pooling for pharmacokinetic studies. | 2005-02-07 |
|
| Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities. | 2005-02-01 |
|
| Synthesis and antimalarial activity of 6-cycloalkylvinyl substituted 1,2,4-trioxanes. | 2004-11-15 |
|
| HPLC-UV method for assaying 99/357, a synthetic trioxane antimalarial derivative in rat and rabbit serum. | 2004-10-29 |
|
| Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore. | 2004-09-02 |
|
| Synthesis and antimalarial activity of trioxaquine derivatives. | 2004-04-02 |
|
| Protein binding and alpha : beta anomer ratio of dihydroartemisinin in vivo. | 2004-04 |
|
| Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents. | 2004-02-26 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:10:18 GMT 2025
by
admin
on
Mon Mar 31 19:10:18 GMT 2025
|
| Record UNII |
46BNU65YNY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
203-812-5
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
38043
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
8081
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
38044
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
m11176
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
3416
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
110-88-3
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
1,3,5-TRIOXANE
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
C011374
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
100000145685
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
46BNU65YNY
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
DTXSID4021925
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
SUB124376
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY | |||
|
26347
Created by
admin on Mon Mar 31 19:10:18 GMT 2025 , Edited by admin on Mon Mar 31 19:10:18 GMT 2025
|
PRIMARY |